A Painful Pill to Swallow
Roddy Boyd of Storm King Reports makes the case that Intra-Cellular Therapies (ITCI) has failed to properly disclose a severe adverse reaction to its blockbuster drug, Caplyta.
Category / Big Announcements
A Toolbox of Accounting Tricks
“JR” of Jehoshaphat Research makes the case that Techtronic Industries (669 HK) has engaged in a practice called “snowballing” to maintain margin growth that can be classified as none other than statistically impossible.
A Hollow Growth Story
Dan David of Wolfpack Research explains that Goosehead Insurance (GSHD) cannibalizes its franchisees’ businesses, causing the vast majority to fail in their first year; and, coupled with a greater than understood reliance on the housing market, makes GSHD an enrichment vehicle for management while investors are poised for losses.
Recent Comments